Purchase 25B-NBOMe, 25C-NBOMe, 25I-NBOMe
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 25B-NBOMe, 25C-NBOMe, 25I-NBOMe for sale
25I-NBOMe, also known as 2C-I-NBOMe, Cimbi-5, and Smiles, is a synthetic hallucinogen used in biochemistry research and for recreational purposes. As a derivative of the 2C-I family of substituted phenethylamine, it is the most well-known member of the 25-NB family. This page seeks to illuminate the complexities of 25I-NBOMe, its effects and ramifications, and the need for caution when handling this chemical.
What is 25I-NBOMe?
25I-NBOMe is a synthetic hallucinogen that alters perception and mood by attaching to the type 2A serotonin receptor in the brain. It is frequently employed in biochemistry research to map the brain's receptor utilization and impact on the human body. Nonetheless, because of its euphoric properties, it has also acquired favor as a recreational drug.
The Discovery of 25I-NBOMe
25I-NBOMe was discovered in 2003 at the Free University of Berlin by chemist Ralf Heim. Later, a team from Purdue University led by David Nichols investigated the chemical and reported their findings.
Uses of 25I-NBOMe
25I-NBOMe is utilized mainly in biochemistry research to map the brain's use of the type 2A serotonin receptor and its physiological consequences. Due to its intoxicating properties, cannabis is also used recreationally.
Effects of 25I-NBOMe
25I-NBOMe has several effects on the human body, including perception, mood, and behavior changes. It is known to create euphoric and stimulating effects that can linger for hours. It is also known to generate an impact comparable to methamphetamine and cocaine.
Dangers of 25I-NBOMe
The ease of accidental overdose is one of the most significant hazards linked with 25I-NBOMe. The chemical is powerful; even small amounts can have fatal health repercussions. Additionally, the long-term harmful consequences of 25I-NBOMe have not been researched, making it impossible to appreciate the hazards connected with its usage completely.
Questions asked frequently
Is 25I-NBOMe legal?
25I-NBOMe is a Schedule I-restricted drug, making it illegal in many nations, including the United States. However, its legality differs from nation to country; therefore, it is crucial to examine the regulations in your particular area.
What are the symptoms of an overdose of 25I-NBOMe?
An overdose of 25I-NBOMe can cause agitation, disorientation, a high body temperature, seizures, and hallucinations. In severe circumstances, the condition might cause coma and death.
Is 25I-NBOMe addictive?
There is insufficient evidence on the possibility of 25I-NBOMe addiction. However, it is regarded to have a low risk for misuse and addiction relative to other substances.
25I-NBOMe is a potent psychedelic having both medicinal and recreational uses. While it has been researched for its effects on the type 2A serotonin receptor, it is vital to approach its usage with caution due to the ease of accidental overdose and the lack of knowledge of its long-term consequences.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics